Literature DB >> 25794615

The p53 C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domain.

Oleg Laptenko1, Idit Shiff2, Will Freed-Pastor1, Andrew Zupnick1, Melissa Mattia1, Ella Freulich1, Inbal Shamir2, Noam Kadouri2, Tamar Kahan2, James Manfredi3, Itamar Simon4, Carol Prives5.   

Abstract

DNA binding by numerous transcription factors including the p53 tumor suppressor protein constitutes a vital early step in transcriptional activation. While the role of the central core DNA binding domain (DBD) of p53 in site-specific DNA binding has been established, the contribution of the sequence-independent C-terminal domain (CTD) is still not well understood. We investigated the DNA-binding properties of a series of p53 CTD variants using a combination of in vitro biochemical analyses and in vivo binding experiments. Our results provide several unanticipated and interconnected findings. First, the CTD enables DNA binding in a sequence-dependent manner that is drastically altered by either its modification or deletion. Second, dependence on the CTD correlates with the extent to which the p53 binding site deviates from the canonical consensus sequence. Third, the CTD enables stable formation of p53-DNA complexes to divergent binding sites via DNA-induced conformational changes within the DBD itself.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25794615      PMCID: PMC6221458          DOI: 10.1016/j.molcel.2015.02.015

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  69 in total

1.  p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

Authors:  A Ito; C H Lai; X Zhao; S Saito; M H Hamilton; E Appella; T P Yao
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination.

Authors:  S Nakamura; J A Roth; T Mukhopadhyay
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Transcript cleavage factors GreA and GreB act as transient catalytic components of RNA polymerase.

Authors:  Oleg Laptenko; Jookyung Lee; Ivan Lomakin; Sergei Borukhov
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

Review 4.  Transcriptional regulation by p53: one protein, many possibilities.

Authors:  O Laptenko; C Prives
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

Review 5.  Methods developed for SELEX.

Authors:  Subash Chandra Bose Gopinath
Journal:  Anal Bioanal Chem       Date:  2006-10-28       Impact factor: 4.142

6.  DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis.

Authors:  Katharina Schlereth; Rasa Beinoraviciute-Kellner; Marie K Zeitlinger; Anne C Bretz; Markus Sauer; Joël P Charles; Fotini Vogiatzi; Ellen Leich; Birgit Samans; Martin Eilers; Caroline Kisker; Andreas Rosenwald; Thorsten Stiewe
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

7.  DECOD: fast and accurate discriminative DNA motif finding.

Authors:  Peter Huggins; Shan Zhong; Idit Shiff; Rachel Beckerman; Oleg Laptenko; Carol Prives; Marcel H Schulz; Itamar Simon; Ziv Bar-Joseph
Journal:  Bioinformatics       Date:  2011-07-12       Impact factor: 6.937

8.  p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation.

Authors:  Oleg Laptenko; Rachel Beckerman; Ella Freulich; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

9.  Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus.

Authors:  J Jayaraman; C Prives
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

10.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

View more
  52 in total

1.  Quantitative Analysis of the DNA Methylation Sensitivity of Transcription Factor Complexes.

Authors:  Judith F Kribelbauer; Oleg Laptenko; Siying Chen; Gabriella D Martini; William A Freed-Pastor; Carol Prives; Richard S Mann; Harmen J Bussemaker
Journal:  Cell Rep       Date:  2017-06-13       Impact factor: 9.423

2.  p16INK4A enhances the transcriptional and the apoptotic functions of p53 through DNA-dependent interaction.

Authors:  Huda H Al-Khalaf; Shreeram C Nallar; Dhananjaya V Kalvakolanu; Abdelilah Aboussekhra
Journal:  Mol Carcinog       Date:  2017-03-06       Impact factor: 4.784

3.  Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding.

Authors:  Fan He; Wade Borcherds; Tanjing Song; Xi Wei; Mousumi Das; Lihong Chen; Gary W Daughdrill; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-15       Impact factor: 11.205

4.  Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.

Authors:  Alexander S Krois; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-12       Impact factor: 11.205

5.  A nuclear phosphoinositide kinase complex regulates p53.

Authors:  Suyong Choi; Mo Chen; Vincent L Cryns; Richard A Anderson
Journal:  Nat Cell Biol       Date:  2019-03-18       Impact factor: 28.824

6.  Diverse p53/DNA binding modes expand the repertoire of p53 response elements.

Authors:  Pratik Vyas; Itai Beno; Zhiqun Xi; Yan Stein; Dmitrij Golovenko; Naama Kessler; Varda Rotter; Zippora Shakked; Tali E Haran
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-14       Impact factor: 11.205

7.  C-terminal region of human p53 attenuates buffalo p53 N-terminal-specific transactivation of p21 promoter by modulating tetramerization of the protein.

Authors:  Minu Singh; Tapas Mukhopadhyay
Journal:  Mol Cell Biochem       Date:  2017-11-16       Impact factor: 3.396

Review 8.  The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Authors:  Oleg Laptenko; David R Tong; James Manfredi; Carol Prives
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

9.  Microchip-Based Structure Determination of Disease-Relevant p53.

Authors:  Maria J Solares; G M Jonaid; William Y Luqiu; Yanping Liang; Madison C Evans; William J Dearnaley; Zhi Sheng; Deborah F Kelly
Journal:  Anal Chem       Date:  2020-10-30       Impact factor: 6.986

Review 10.  The multiple mechanisms that regulate p53 activity and cell fate.

Authors:  Antonina Hafner; Martha L Bulyk; Ashwini Jambhekar; Galit Lahav
Journal:  Nat Rev Mol Cell Biol       Date:  2019-04       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.